NGM BIOPHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding from Q1 2019 to Q1 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Ngm Biopharmaceuticals Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2019 to Q1 2024.
  • Ngm Biopharmaceuticals Inc Entity Common Stock, Shares Outstanding for the quarter ending March 5, 2024 was 83.5M shares, a 1.34% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 83.5M +1.1M +1.34% Mar 5, 2024 10-K/A 2024-04-04
Q3 2023 82.7M +989K +1.21% Oct 30, 2023 10-Q 2023-11-02
Q2 2023 82.7M +2.35M +2.92% Jul 31, 2023 10-Q 2023-08-03
Q1 2023 82.4M +3.1M +3.91% May 1, 2023 10-Q 2023-05-04
Q3 2022 81.7M +4.02M +5.17% Oct 31, 2022 10-Q 2022-11-03
Q2 2022 80.4M +3.03M +3.92% Aug 1, 2022 10-Q 2022-08-04
Q1 2022 79.3M +2.56M +3.34% May 2, 2022 10-Q 2022-05-05
Q3 2021 77.7M +8.69M +12.6% Nov 1, 2021 10-Q 2021-11-04
Q2 2021 77.3M +8.51M +12.4% Aug 2, 2021 10-Q/A 2021-11-04
Q1 2021 76.7M +8.94M +13.2% Mar 10, 2021 10-K/A 2021-11-04
Q3 2020 69M +2.36M +3.55% Nov 9, 2020 10-Q 2020-11-12
Q2 2020 68.8M +2.78M +4.22% Aug 7, 2020 10-Q 2020-08-12
Q1 2020 67.8M +1.73M +2.62% Mar 12, 2020 10-K 2020-03-17
Q3 2019 66.7M Nov 8, 2019 10-Q 2019-11-12
Q2 2019 66M Aug 9, 2019 10-Q 2019-08-12
Q1 2019 66M May 10, 2019 10-Q 2019-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.